[go: up one dir, main page]

ES2068163B1 - PROCEDURE FOR OBTAINING A PLANT EXTRACT WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES. - Google Patents

PROCEDURE FOR OBTAINING A PLANT EXTRACT WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES.

Info

Publication number
ES2068163B1
ES2068163B1 ES9400957A ES9400957A ES2068163B1 ES 2068163 B1 ES2068163 B1 ES 2068163B1 ES 9400957 A ES9400957 A ES 9400957A ES 9400957 A ES9400957 A ES 9400957A ES 2068163 B1 ES2068163 B1 ES 2068163B1
Authority
ES
Spain
Prior art keywords
neuroinmunes
activity
treatment
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9400957A
Other languages
Spanish (es)
Other versions
ES2068163A1 (en
Inventor
Almagro Eliseo Quintanilla
Alperi Joaquin Diaz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Especialidades Farmaceuticas Centrum SA
Original Assignee
Especialidades Farmaceuticas Centrum SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Especialidades Farmaceuticas Centrum SA filed Critical Especialidades Farmaceuticas Centrum SA
Priority to ES9400957A priority Critical patent/ES2068163B1/en
Publication of ES2068163A1 publication Critical patent/ES2068163A1/en
Priority to AT95500063T priority patent/ATE222112T1/en
Priority to DE69527742T priority patent/DE69527742T2/en
Priority to PT95500063T priority patent/PT680762E/en
Priority to EP95500063A priority patent/EP0680762B1/en
Priority to DK95500063T priority patent/DK0680762T3/en
Priority to US08/433,621 priority patent/US5601829A/en
Priority to JP7134773A priority patent/JP2779780B2/en
Application granted granted Critical
Publication of ES2068163B1 publication Critical patent/ES2068163B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

UNA COMPOSICION FARMACEUTICA CON ACTIVIDAD EN EL TRATAMIENTO DE DISFUNCIONES COGNITIVAS Y/O NEUROINMUNES, EN ESPECIAL LA ENFERMEDAD DE ALZHEIMER. COMPRENDE UN EXTRACTO HIDROSOLUBLE NATURAL AISLADO DEL RIZOMA Y HOJAS DEL PHLEBODIUM DECUMANUM, POLYPODIUM AUREUM, POLYPODIUM LEUCOTOMOS, POLYPODIUM VULGARE, POLYPODIUM TRISEREIALE, PTERIDIUM AQUILINUM, DRYOPTERIS CRASSIRHIZOMA Y CYATHEA TAIWAMIANA, Y UN VEHICULO FARMACEUTICAMENTE ACEPTABLE.A PHARMACEUTICAL COMPOSITION WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES, ESPECIALLY ALZHEIMER'S DISEASE. COMPRISES OF A NATURAL WATER-SOLUBLE EXTRACT ISOLATED FROM THE RHIZOMA AND LEAVES OF THE PHLEBODIUM DECUMANUM, POLYPODIUM AUREUM, POLYPODIUM LEUCOTOMOS, POLYPODIUM VULGARE, YACHTER, YACHTER, PTERIDIUM AQUILIN,

ES9400957A 1994-05-06 1994-05-06 PROCEDURE FOR OBTAINING A PLANT EXTRACT WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES. Expired - Fee Related ES2068163B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ES9400957A ES2068163B1 (en) 1994-05-06 1994-05-06 PROCEDURE FOR OBTAINING A PLANT EXTRACT WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES.
EP95500063A EP0680762B1 (en) 1994-05-06 1995-04-27 Pharmaceutical composition comprising fern extract(s) for the treatment of neurodegenerative diseases.
DE69527742T DE69527742T2 (en) 1994-05-06 1995-04-27 Pharmaceutical composition containing fern extract (s) for the treatment of neurodegenerative diseases.
PT95500063T PT680762E (en) 1994-05-06 1995-04-27 PHARMACEUTICAL COMPOSITION UNDERSTANDING EXTRACT (S) OF DONE FOR TREATMENT OF NEURODEGENERATIVE DISFUNCHES
AT95500063T ATE222112T1 (en) 1994-05-06 1995-04-27 PHARMACEUTICAL COMPOSITION CONTAINING FERN EXTRACT(S) FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES.
DK95500063T DK0680762T3 (en) 1994-05-06 1995-04-27 Pharmaceutical composition for use in the treatment of neurodegenerative dysfunctions
US08/433,621 US5601829A (en) 1994-05-06 1995-05-03 Pharmaceutical composition of activity in the treatment of cognitive and/or neuroimmune dysfunctions
JP7134773A JP2779780B2 (en) 1994-05-06 1995-05-08 Cognitive dysfunction therapeutic agent and / or Alzheimer's disease therapeutic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9400957A ES2068163B1 (en) 1994-05-06 1994-05-06 PROCEDURE FOR OBTAINING A PLANT EXTRACT WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES.

Publications (2)

Publication Number Publication Date
ES2068163A1 ES2068163A1 (en) 1995-04-01
ES2068163B1 true ES2068163B1 (en) 1995-09-01

Family

ID=8286124

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9400957A Expired - Fee Related ES2068163B1 (en) 1994-05-06 1994-05-06 PROCEDURE FOR OBTAINING A PLANT EXTRACT WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES.

Country Status (1)

Country Link
ES (1) ES2068163B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2124675A1 (en) * 1997-07-30 1999-02-01 Helsint S A L Helechos Interna Formulations based on a water-soluble fraction of Phlebodium decumanum, and use thereof in the treatment of the cachectic syndrome in AIDS patients
WO1999006058A1 (en) * 1997-07-30 1999-02-11 Helsint, S.A.L. Hydrosoluble fractions of phlebodium decumanum and use thereof as nutritional complements in aids and cancer patients
ES2137900A1 (en) * 1998-06-02 1999-12-16 Helsint S A L Use of formulations based on a water-soluble fraction of Phlebodium decumanum as a nutritional complement in the treatment of the cachectic syndrome in oncological patients.
WO2000043022A1 (en) * 1999-01-22 2000-07-27 Helsint, S.A.L. Utilization of formulations based on water-soluble fractions of phlebodium decumanum(exply-37) and polypodium leucotomos as nutritional supplement in the prevention and reversion of excessive physical effort syndrome

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2088770B1 (en) * 1995-02-23 1997-03-16 Esp Farmaceuticas Centrum Sa A PHARMACEUTICAL COMPOSITION WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395223A (en) * 1965-05-13 1968-07-30 Carter Wallace Fern extract for treating gastric ulcers
US3839553A (en) * 1970-08-13 1974-10-01 T Hernandez Cosmetic and conditioner for skin and hair
FR2395266A1 (en) * 1977-06-23 1979-01-19 Suffren Ste Parti Brevets -LACTONE MONOMERS AND THEIR POLYMERS, SALTS AND DERIVATIVES, USED IN PARTICULAR AS COLORS, TANNING ADDICTS AND MEDICINAL PRODUCTS
ES470204A1 (en) * 1978-05-24 1979-01-01 Conrad Ltd PROCEDURE FOR OBTAINING NATURAL TERPENES WITH ANTIPSORIATIC ACTIVI-DAD
ES471572A1 (en) * 1978-07-07 1979-01-16 Conrad Ltd PROCEDURE FOR OBTAINING NATURAL POLAR FRACTION WITH ANTIPSORIATIC ACTIVITY
ES8605536A1 (en) * 1985-10-03 1986-03-16 Vargas Gonzalez Jose Extn. of ecdysone from plants
US4886666A (en) * 1987-01-27 1989-12-12 Yaguang Liu Pharmaceutical composition for inhibiting viruses and increasing immune function (PII)
ES2012734A6 (en) * 1989-06-14 1990-04-01 Gonzalez Jose Francisco Vargas Procedure for obtaining alpha-d-gluco-octono-delta-lacton- eno-diol and the calcium salt thereof
EP0503208A1 (en) * 1991-03-08 1992-09-16 Maracuyama International, S.A. Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2124675A1 (en) * 1997-07-30 1999-02-01 Helsint S A L Helechos Interna Formulations based on a water-soluble fraction of Phlebodium decumanum, and use thereof in the treatment of the cachectic syndrome in AIDS patients
WO1999006058A1 (en) * 1997-07-30 1999-02-11 Helsint, S.A.L. Hydrosoluble fractions of phlebodium decumanum and use thereof as nutritional complements in aids and cancer patients
ES2137900A1 (en) * 1998-06-02 1999-12-16 Helsint S A L Use of formulations based on a water-soluble fraction of Phlebodium decumanum as a nutritional complement in the treatment of the cachectic syndrome in oncological patients.
WO2000043022A1 (en) * 1999-01-22 2000-07-27 Helsint, S.A.L. Utilization of formulations based on water-soluble fractions of phlebodium decumanum(exply-37) and polypodium leucotomos as nutritional supplement in the prevention and reversion of excessive physical effort syndrome
ES2146555A1 (en) * 1999-01-22 2000-08-01 Helsint S A L Utilization of formulations based on water-soluble fractions of phlebodium decumanum(exply-37) and polypodium leucotomos as nutritional supplement in the prevention and reversion of excessive physical effort syndrome

Also Published As

Publication number Publication date
ES2068163A1 (en) 1995-04-01

Similar Documents

Publication Publication Date Title
RS49963B (en) Composition comprising a nutritious material and a herbal extract useful for prevention and treatment of human immunodeficiency virus and other infective diseases
DK0680762T3 (en) Pharmaceutical composition for use in the treatment of neurodegenerative dysfunctions
DE60206474D1 (en) PROCESS FOR THE PRODUCTION OF A MATRINE-CONTAINING PLANT EXTRACT
ES2016400B3 (en) MEDICINAL PREPARATIONS BASED ON BREWERY POMACE EXTRACT, PROCEDURES FOR ITS OBTAINING AND APPLICATION OF THE BREWERY POMACE EXTRACT IN OBTAINING COSMETIC PREPARATIONS AND A SPECIAL BREWERY POMACE EXTRACT.
WO1997013489A3 (en) Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions
EP0491913A4 (en) Chinese herbal extracts in the treatment of hiv related disease
FR2811573B1 (en) PROCESS FOR THE PREPARATION OF A POWERFUL EXTRACT OF ANTI-INFLAMMATORY ACTIVITIES, PLATELET AND ANTIFUNGAL ANTI-AGGREGATION FROM OFFICINAL ZINGIBER AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID EXTRACT
ES2068163B1 (en) PROCEDURE FOR OBTAINING A PLANT EXTRACT WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES.
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
ES2088770B1 (en) A PHARMACEUTICAL COMPOSITION WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES.
RU95119282A (en) COMPOSITION OF INGREDIENTS FOR MEDICINAL PRODUCT
EE9400241A (en) Herbal medicinal product
RU94019563A (en) BIOLOGICAL ACTIVE CREAM
RU94036437A (en) Method for treatment of cardiovascular diseases and preparation for its treatment
Sini et al. Antimicrobial properties of roots of medicinal plants
RU92006716A (en) SOLID MEDICINE FORM - ELEATEROCOCCOO TABLET
DE69312067D1 (en) RECTAL PHARMACEUTICAL PREPARATION FOR TREATING PROSTATE SWELLING
FR2746646B1 (en) SOOTHING COMPOSITION COMPRISING A PLANT EXTRACT AND A BACTERIAL EXTRACT
GEU1999424Y (en) Medicinal Ointment “Mdivnishvili-1”
GEU1999480Y (en) Medicinal Means “Valenuri”
EP0319879A3 (en) Judas tree extract as a prophylactic and/or therapeutic preparation
GEU1999425Y (en) Medicinal Ointment “Mdivnishvili -7”
GEU1999444Y (en) Medicinal Means “Barambo”
Simons et al. Immunomodulatory Compounds from Picrorhiza kurroa: Isolation and Characterization of two Anticomplementary Polymeric Fractions from an Aqueous Root Extract
王广树 et al. Isolation and Structure Elucidation of New Glycosides From the Leaves of Oplopanax Elatus NAKAI (Ⅲ)

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040503